Patient Guide: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 33 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04939142
Status: ACTIVE_NOT_RECRUITING
Condition: Relapsed or Refractory Multiple Myeloma
Phase: PHASE3

Find a Study Location Near You

This study is available at 33 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Hefei, Anhui
  • Hefei, Anhui
  • Wuhu, Anhui
  • • And 30 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily